Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors
Zebin Xiao, Leslie Todd, Li Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
Steven Μ. Albelda
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 47-66
Closed Access | Times Cited: 182
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 38
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors
T. R. Chen, Mingzhao Wang, Yanchao Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 37
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 28
Mitochondrial metabolism sustains CD8+ T cell migration for an efficient infiltration into solid tumors
Luca Simula, Mattia Fumagalli, Lene Vimeux, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Beyond the blood: expanding CAR T cell therapy to solid tumors
Uğur Uslu, Carl H. June
Nature Biotechnology (2024)
Closed Access | Times Cited: 20
Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 18
Targeting Cancer‐Associated Fibroblasts: Eliminate or Reprogram?
Masaya Yamazaki, Takatsugu Ishimoto
Cancer Science (2025)
Open Access | Times Cited: 4
Emerging role of immune cells as drivers of pulmonary fibrosis
Steven E. Mutsaers, Tylah Miles, Cecilia M. Prêle, et al.
Pharmacology & Therapeutics (2023) Vol. 252, pp. 108562-108562
Closed Access | Times Cited: 23
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Clinical immunotherapy in pancreatic cancer
Xiaorong Ye, Yue Yu, Xiaohu Zheng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 4
Open Access | Times Cited: 14
Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis
Sarah Ash, Rebecca Orha, Holly Mole, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008608-e008608
Open Access | Times Cited: 12
Compressive stresses in cancer: characterization and implications for tumour progression and treatment
Julia A Linke, Lance L. Munn, Rakesh K. Jain
Nature reviews. Cancer (2024) Vol. 24, Iss. 11, pp. 768-791
Closed Access | Times Cited: 11
Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy
Miguel Pereira‐Silva, Darío Miranda-Pastoriza, Luis Díaz‐Gómez, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 95-95
Open Access | Times Cited: 9
Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures
Florent Peyraud, Jean-Philippe Guégan, Christophe Rey, et al.
Cell Reports Medicine (2025), pp. 101934-101934
Open Access | Times Cited: 1
Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
Kohei Okuyama, Maiko Tsuchiya, Kala Chand Debnath, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access | Times Cited: 1
Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy
Yuxin Zhang, Jie Zhou, Yiyan Wang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113606-113606
Closed Access | Times Cited: 1
The mechanopathology of the tumor microenvironment: detection techniques, molecular mechanisms and therapeutic opportunities
Simón I. Angeli, Constantina Neophytou, Maria Kalli, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1
Flexocatalytic Reduction of Tumor Interstitial Fluid/Solid Pressure for Efficient Nanodrug Penetration
Anshuo Li, Tiantian Zhang, Xuwu Zhang, et al.
ACS Nano (2024)
Closed Access | Times Cited: 8
Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1
Tri Tran, Bal Krishna Chand Thakuri, Saule Nurmukhambetova, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008261-e008261
Open Access | Times Cited: 7
Advances in targeting tumor microenvironment for immunotherapy
Lugang Wang, Liubo Zhang, Zhen Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer
Uri Amit, Uğur Uslu, Ioannis I. Verginadis, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 31
Open Access | Times Cited: 6
Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 6
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189065-189065
Closed Access | Times Cited: 14
A Synergistic Chemoimmunotherapy System Leveraging PD‐L1 Blocking and Bioorthogonal Prodrug Activation
Kewei Wang, Maolin Jiang, Tao Li, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top